Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nature

• Publication date

  2012-08-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature11333PMID 22902501PMCID PMC5176099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain.

  2011cited by this paper
• Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.

  2011cited by this paper
• Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells.

  2011cited by this paper
• High sensitivity 5-hydroxymethylcytosine detection in Balb/C brain tissue.

  2011cited by this paper
• Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells

  2011cited by this paper
• TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity

  2011cited by this paper
• Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells.

  2011cited by this paper
• Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells.

  2011cited by this paper
• Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation

  2011cited by this paper
• Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells

  2011cited by this paper
• DNA demethylation dynamics.

  2011cited by this paper
• The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets.

  2010cited by this paper
• Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.

  2010cited by this paper
• Genome-Wide Reprogramming in the Mouse Germ Line Entails the Base Excision Repair Pathway

  2010cited by this paper
• Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

  2010cited by this paper
• Dynamic single-cell imaging of direct reprogramming reveals an early specifying event

  2010cited by this paper
• The Zn3 Domain of Human Poly(ADP-ribose) Polymerase-1 (PARP-1) Functions in Both DNA-dependent Poly(ADP-ribose) Synthesis Activity and Chromatin Compaction*

  2010cited by this paper
• Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification

  2010cited by this paper
• Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1

  2009cited by this paper
• The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain

  2009cited by this paper
• Dissecting direct reprogramming through integrative genomic analysis

  2008cited by this paper
• Genome-scale DNA methylation maps of pluripotent and differentiated cells

  2008cited by this paper
• Dissecting direct reprogramming through integrative genomic analysis

  2008cited by this paper
• The DNA Binding and Catalytic Domains of Poly(ADP-Ribose) Polymerase 1 Cooperate in the Regulation of Chromatin Structure and Transcription

  2007cited by this paper
• Genome-wide maps of chromatin state in pluripotent and lineage-committed cells

  2007cited by this paper
• Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome

  2007cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• A bivalent chromatin structure marks key developmental genes in embryonic stem cells.

  2006cited by this paper
• Control of developmental regulators by Polycomb in human embryonic stem cells.

  2006cited by this paper
• Genomic maps and comparative analysis of histone modifications in human and mouse.

  2005cited by this paper
• Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.

  1995cited by this paper

• Two decades of induced pluripotent stem cell research: From discovery to diverse applications.

  2026cites this paper
• Epigenetic consequences of DNA damage.

  2026cites this paper
• A ternary-code DNA methylome atlas of mouse tissues

  2025cites this paper
• Molecular basis of cell fate plasticity - insights from the privileged cells.

  2025cites this paper
• Cell identity and 5-hydroxymethylcytosine

  2025cites this paper
• Proteogenomic reprogramming to a functional human blastomere-like stem cell state via a PARP-DUX4 regulatory axis

  2025cites this paper
• Cell reprogramming: methods, mechanisms and applications

  2025cites this paper
• Effects of polystyrene microparticles exposures on spermatogenic cell differentiation and reproductive endpoints in male mice.

  2025cites this paper
• CHD1L in cancer and beyond: structure, oncogenic functions, and therapeutic potential

  2025cites this paper
• Hybrid Platinum(IV)-Naproxen Nanostructured Drugs Reprogram Melanoma Cells and Overpower Cisplatin

  2025cites this paper
• Epigenetic mechanisms of PARP inhibitor resistance in ovarian cancer: A systematic review with bioinformatic analysis of clinically actionable genes.

  2025cites this paper
• TRIM37–PARP1–TET1 axis maintains stemness and prevents osteoporosis by inhibiting DNMT1 alternative splicing via 5hmC regulation

  2025influential citation
• Deciphering the TET3 interactome in primary thymic developing T cells

  2024cites this paper
• Genome-wide ATAC-see screening identifies TFDP1 as a modulator of global chromatin accessibility

  2024cites this paper
• A Stem-like Patient-Derived Ovarian Cancer Model of Platinum Resistance Reveals Dissociation of Stemness and Resistance

  2024cites this paper
• Manipulating cell fate through reprogramming: approaches and applications.

  2024cites this paper
• Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications

  2024cites this paper
• Interplay between pioneer transcription factors and epigenetic modifiers in cell reprogramming

  2024cites this paper
• iPS cell generation-associated point mutations include many C > T substitutions via different cytosine modification mechanisms

  2024cites this paper
• The interferon γ pathway enhances pluripotency and X-chromosome reactivation in iPSC reprogramming

  2024cites this paper
• 5-Hydroxymethylcytosine: Far Beyond the Intermediate of DNA Demethylation

  2024cites this paper
• BRCA1 and 53BP1 regulate reprogramming efficiency by mediating DNA repair pathway choice at replication-associated double-strand breaks.

  2024cites this paper
• Metabolic control of induced pluripotency

  2024cites this paper
• Stem Cell Therapy as a Potential Treatment of Non-Alcoholic Steatohepatitis-Related End-Stage Liver Disease: A Narrative Review

  2024cites this paper
• Transcriptional regulation mechanism of PARP1 and its application in disease treatment

  2024cites this paper
• Beneficial Effects of Manilkara zapota-Derived Bioactive Compounds in the Epigenetic Program of Neurodevelopment

  2024cites this paper
• Transcriptional Factors mediated Reprogramming to Pluripotency.

  2023cites this paper
• TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential

  2023cites this paper
• The thyroid hormone enhances mouse embryonic fibroblasts reprogramming to pluripotent stem cells: role of the nuclear receptor corepressor 1

  2023cites this paper
• Vitamin C activates young LINE-1 elements in mouse embryonic stem cells via H3K9me3 demethylation

  2023cites this paper
• Tet2 regulates Sin3a recruitment at active enhancers in embryonic stem cells

  2023influential citation
• Epigenetics as a mediator of plasticity in cancer

  2023cites this paper
• Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency

  2023cites this paper
• Poly (ADP-Ribose) Polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities.

  2023cites this paper
• The Interferon γ Pathway Enhances Pluripotency and X-Chromosome Reactivation in iPSC reprogramming

  2023cites this paper
• Role of Vitamin C in Targeting Cancer Stem Cells and Cellular Plasticity

  2023cites this paper
• Multiomics analysis of the NAD+–PARP1 axis reveals a role for site-specific ADP-ribosylation in splicing in embryonic stem cells

  2022influential citation
• HIF-1α mediates renal fibrosis by regulating metabolic remodeling of renal tubule epithelial cells.

  2022cites this paper
• Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies.

  2022cites this paper
• PARP1: Liaison of Chromatin Remodeling and Transcription

  2022cites this paper
• DNA Methylation Malleability and Dysregulation in Cancer Progression: Understanding the Role of PARP1

  2022cites this paper
• Sin3a drives mesenchymal-to-epithelial transition through cooperating with Tet1 in somatic cell reprogramming

  2022cites this paper
• Dissecting TET2 Regulatory Networks in Blood Differentiation and Cancer

  2022cites this paper
• Mechanism of DNA Methylation in Stem Cells

  2022cites this paper
• Crosstalk of moderate ROS and PARP‐1 contributes to sustainable proliferation of conditionally reprogrammed keratinocytes

  2022cites this paper
• Structure and Function of TET Enzymes.

  2022cites this paper
• Resolving Geroplasticity to the Balance of Rejuvenins and Geriatrins

  2022cites this paper
• Tet2- and Tet3-Mediated Cytosine Hydroxymethylation in Six2 Progenitor Cells in Mice Is Critical for Nephron Progenitor Differentiation and Nephron Endowment

  2022cites this paper
• iPSC-based model of Vogt-Koyanagi-Harada disease for phenotype recapitulation and drug screening.

  2022cites this paper
• Role of NAD+ and FAD in Ischemic Stroke Pathophysiology: An Epigenetic Nexus and Expanding Therapeutic Repertoire

  2022cites this paper
• Dissecting dual roles of MyoD during lineage conversion to mature myocytes and myogenic stem cells

  2021cites this paper
• Pronounced sequence specificity of the TET enzyme catalytic domain guides its cellular function

  2021cites this paper
• TET1 controls Cxcl1 induction by DNA demethylation and promotes neutrophil recruitment during acute lung injury

  2021cites this paper
• Oral tissues as sources for induced pluripotent stem cell derivation and their applications for neural, craniofacial, and dental tissue regeneration

  2021cites this paper
• AKT signaling is associated with epigenetic reprogramming via the upregulation of TET and its cofactor, alpha-ketoglutarate during iPSC generation

  2021cites this paper
• Induced Tissue-Specific Stem Cells (iTSCs): Their Generation and Possible Use in Regenerative Medicine

  2021cites this paper
• Ascorbic acid in epigenetic reprogramming.

  2021cites this paper
• The PARP Way to Epigenetic Changes

  2021cites this paper
• Precision Autism: Genomic Stratification of Disorders Making Up the Broad Spectrum May Demystify Its “Epidemic Rates”

  2021cites this paper
• Stem Cell Therapies in Alzheimer’s Disease: Applications for Disease Modeling

  2021cites this paper
• Poly (ADP-ribose) polymerase (PARP) inhibition in cancer: Potential impact in cancer stem cells and therapeutic implications.

  2021cites this paper
• The Complexity of TET2 Functions in Pluripotency and Development

  2021influential citation
• Identification of Homozygous Mutations for Hearing Loss.

  2021cites this paper
• The effects of vitamins and dietary pattern on epigenetic modification of non-communicable diseases.

  2021cites this paper
• Induced pluripotent stem cell technology: trends in molecular biology, from genetics to epigenetics.

  2021cites this paper
• Active turnover of DNA methylation during cell fate decisions

  2020cites this paper
• Mthfd2 Modulates Mitochondrial Function and DNA Repair to Maintain the Pluripotency of Mouse Stem Cells

  2020cites this paper
• Going up the hill: chromatin‐based barriers to epigenetic reprogramming

  2020cites this paper
• Epithelial-Mesenchymal Transition and Metabolic Switching in Cancer: Lessons From Somatic Cell Reprogramming

  2020cites this paper
• DNA methylation and the core pluripotency network.

  2020cites this paper
• Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa

  2020cites this paper
• Epigenetic regulation of cancer stem cell formation and maintenance

  2020cites this paper
• The Multifactorial Role of PARP-1 in Tumor Microenvironment

  2020cites this paper
• The Zscan4-Tet2 Transcription Nexus Regulates Metabolic Rewiring and Enhances Proteostasis to Promote Reprogramming.

  2020cites this paper
• EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells

  2020cites this paper
• Selective targeting of TET catalytic domain promotes somatic cell reprogramming

  2020cites this paper
• HIF‐1α/Actl6a/H3K9ac axis is critical for pluripotency and lineage differentiation of human induced pluripotent stem cells

  2020cites this paper
• The role of DNA demethylation in induction of stem cells.

  2020cites this paper
• Active turnover of DNA methylation during cell fate decisions

  2020cites this paper
• Epigenetics of Somatic Cell Reprogramming

  2020cites this paper
• Genome-wide interaction target profiling reveals a novel Peblr20-eRNA activation pathway to control stem cell pluripotency

  2020cites this paper
• L-Ascorbic Acid in the Epigenetic Regulation of Cancer Development and Stem Cell Reprogramming

  2020cites this paper
• Targeted expression profiling reveals distinct stages of early canine fibroblast reprogramming are regulated by 2-oxoglutarate hydroxylases

  2020cites this paper
• Epigenetics in Stem Cell Biology

  2020cites this paper
• TET2 rs1548483 SNP Associating with Susceptibility to Molecularly Annotated Polycythemia Vera and Primary Myelofibrosis

  2020cites this paper
• Towards resolving the enigma of the dichotomy of resveratrol: cis- and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation

  2020cites this paper
• Regenerative Medicine and Stem Cell Biology

  2020cites this paper
• Dynamic 3D Chromatin Reorganization during Establishment and Maintenance of Pluripotency

  2020cites this paper
• Functionally distinct roles for TET-oxidized 5-methylcytosine bases in somatic reprogramming to pluripotency.

  2020cites this paper
• TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells.

  2020cites this paper
• Therapeutic considerations of PARP in stem cell biology: relevance in cancer and beyond.

  2019cites this paper
• Reprogramming the Epigenome With Vitamin C

  2019cites this paper
• Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy.

  2019cites this paper
• Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells

  2019cites this paper
• The Human TET2 Gene Contains Three Distinct Promoter Regions With Differing Tissue and Developmental Specificities

  2019cites this paper
• Mutational Profile of Aggressive, Localised Prostate Cancer from African Caribbean Men Versus European Ancestry Men.

  2019cites this paper
• Metabolic–Epigenetic Axis in Pluripotent State Transitions

  2019cites this paper
• Genome-wide characterization of cytosine-specific 5-hydroxymethylation in normal breast tissue

  2019cites this paper
• Temporal Dynamics of Tet1 and Oct4 Gene Activation Resolve Distinct Stages of Global DNA Demethylation and Transcriptomic Changes in the Final Phases of Induced Pluripotency

  2019cites this paper
• Secretome of Mesenchymal Stem Cells and Its Potential Protective Effects on Brain Pathologies

  2019cites this paper